Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...
Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best small cap stocks with biggest upside potential. On August 7, Guggenheim lowered the firm’s price target on Structure Therapeutics to $90 ...
Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results